Ocugen (OCGN) Share-based Compensation Growth (3y) (2017 - 2026)
Ocugen (OCGN) Share-based Compensation Growth (3y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Stock Comp. Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
4.80% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
10.78% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Ocugen |
411.07 Mn |
411.07 Mn |
- |
8.11% |
| Date | Value |
|---|
| Mar 31, 2026 |
8.11% |
| Dec 31, 2025 |
-9.13% |
| Sep 30, 2025 |
-7.48% |
| Jun 30, 2025 |
-29.10% |
| Mar 31, 2025 |
-17.02% |
| Dec 31, 2024 |
-11.24% |
| Sep 30, 2024 |
11.99% |
| Jun 30, 2024 |
-3.24% |
| Mar 31, 2024 |
28.34% |
| Dec 31, 2023 |
119.42% |
| Sep 30, 2023 |
158.40% |
| Jun 30, 2023 |
160.44% |
| Mar 31, 2023 |
129.66% |
| Dec 31, 2022 |
153.39% |
| Sep 30, 2022 |
134.69% |
| Jun 30, 2022 |
164.93% |
| Mar 31, 2022 |
99.55% |
| Dec 31, 2021 |
101.36% |
| Sep 30, 2021 |
45.42% |
| Jun 30, 2021 |
72.52% |
